Scleroderma

Fibrotic Diseases of the Retroperitoneum & Skin, & Rare Scleroderma Mimics

January 19, 2018 • By Susan Bernstein

The Role of Macrophages in Inflammation & Fibrosis: Macrophages May Predict Progressive Skin Disease

August 15, 2017 • By Thomas R. Collins

Molecular Differences Between Pediatric & Adult Psoriasis Plaques

July 10, 2017 • By Marilynn Larkin

More Effective Antifibrotic Therapies for Systemic Sclerosis in Development; Adverse Events A Concern

June 14, 2017 • By Susan Bernstein

Stem Cell Transplantation Shown to Improve Outcomes in Systemic Sclerosis

June 14, 2017 • By Mary Beth Nierengarten

Tofacitinib Treatment May Improve Nail Psoriasis

April 24, 2017 • By Rita Buckley

What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities

March 3, 2017 • By Richard Quinn

Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial

March 1, 2017 • By Michele B. Kaufman, PharmD, BCGP

Distinct Autoantigens Found in Patients with Scleroderma & Coincident Cancer

January 24, 2017 • By Lara C. Pullen, PhD

Targeted Therapy for Scleroderma Fibrosis

October 11, 2016 • By Sara R. Schoenfeld, MD, & Flavia V. Castelino, MD